← Leaderboards
Thomas Michel
Brigham And Women'S Hospital
$27,999,083
Attributed
$27,999,083
Total exposure
14
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.3M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$47,384,487 · 15
By mechanism
P01$23,865,537 · 6
R01$12,977,961 · 4
U09$4,999,000 · 1
TL1$3,390,461 · 1
R33$1,027,100 · 1
P50$644,028 · 1
Top collaborators
No co-investigators on record.
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Kellie Rae Machlus$5,242,384
- Fotios Spyropoulos$567,276
- Joseph Loscalzo$36,255,197
- William Michael Oldham$3,432,068
- John A Badwey$2,681,654
Others in their field
Top investigators on “Programs”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,641,009,751
- Leonard Freedman · Leidos Biomedical Research, Inc.$994,984,644
- Lawrence Corey · Fred Hutchinson Cancer Center$730,186,538
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$609,313,548
Research focus
ProgramsFunctional DisorderBlood VesselsEndothelial CellsPhosphorylationNitric Oxide SynthaseCaveolinsResponseMolecularProteinsSignal PathwayPathway InteractionsOxidative StressOxidation-ReductionNitric OxidePreparationLeadCaveolaeSignal TransductionVascular EndotheliumRegulationResearch PersonnelBaseReactive Oxygen Species
Grant awards (80)
Chemogenetic Neurovascular Oxidative Stress: Neurodegeneration and Cardiac Remodeling$698,827
R01 · FY2025 · NS · contact PI
Chemogenetic neurovascular oxidative stress: neurodegeneration and cardiac remodeling$776,474
R01 · FY2024 · NS · contact PI
Hydrogen peroxide in endothelial function and dysfunction$442,178
R01 · FY2024 · HL · contact PI
Hydrogen peroxide in endothelial function and dysfunction$442,178
R01 · FY2023 · HL · contact PI
NRSA Training Core$723,970
TL1 · FY2022 · TR · contact PI
Dynamic tissue-specific modulation of redox stress using chemogenetics$513,456
R33 · FY2022 · HL · contact PI
Hydrogen peroxide in endothelial function and dysfunction$442,165
R01 · FY2022 · HL · contact PI
Hydrogen peroxide in endothelial function and dysfunction$413,067
R01 · FY2022 · HL · contact PI
NRSA Training Core$678,144
TL1 · FY2021 · TR · contact PI
Dynamic tissue-specific modulation of redox stress using chemogenetics$513,644
R33 · FY2021 · HL · contact PI
Hydrogen peroxide in endothelial function and dysfunction$442,069
R01 · FY2021 · HL · contact PI
NRSA Training Core$670,342
TL1 · FY2020 · TR · contact PI
Chemogenetic approaches to define the roles of redox dysfunction in the cardiomyopathy of aging$216,640
R21 · FY2020 · AG · contact PI
NRSA Training Core$662,722
TL1 · FY2019 · TR · contact PI
Chemogenetic approaches to define the roles of redox dysfunction in the cardiomyopathy of aging$263,760
R21 · FY2019 · AG · contact PI
NRSA Training Core$655,283
TL1 · FY2018 · TR · contact PI
Arterial Dysfunction: Basic and Clinical Mechanisms$1,808,610
P01 · FY2014 · HL · contact PI
REDOX REGULATION OF eNOS SIGNALING PATHWAYS IN VASCULAR ENDOTHELIUM$402,340
P01 · FY2014 · HL · contact PI
ANIMAL MODELS OF REDOX METABOLISM AND ARTERIAL DYSFUNCTION$216,913
P01 · FY2014 · HL · contact PI
ADMINISTRATION$89,923
P01 · FY2014 · HL · contact PI
Arterial Dysfunction: Basic and Clinical Mechanisms$1,756,936
P01 · FY2013 · HL · contact PI
REDOX REGULATION OF eNOS SIGNALING PATHWAYS IN VASCULAR ENDOTHELIUM$390,845
P01 · FY2013 · HL · contact PI
ANIMAL MODELS OF REDOX METABOLISM AND ARTERIAL DYSFUNCTION$210,714
P01 · FY2013 · HL · contact PI
ADMINISTRATION$87,356
P01 · FY2013 · HL · contact PI
Arterial Dysfunction: Basic and Clinical Mechanisms$1,845,520
P01 · FY2012 · HL · contact PI
REDOX REGULATION OF eNOS SIGNALING PATHWAYS IN VASCULAR ENDOTHELIUM$410,549
P01 · FY2012 · HL · contact PI
ANIMAL MODELS OF REDOX METABOLISM AND ARTERIAL DYSFUNCTION$221,340
P01 · FY2012 · HL · contact PI
ADMINISTRATION$91,760
P01 · FY2012 · HL · contact PI
Arterial Dysfunction: Basic and Clinical Mechanisms$1,845,520
P01 · FY2011 · HL · contact PI
Endothelial nitric oxide synthase$433,659
R01 · FY2011 · HL · contact PI
REDOX REGULATION OF eNOS SIGNALING PATHWAYS IN VASCULAR ENDOTHELIUM$410,549
P01 · FY2011 · HL · contact PI
ANIMAL MODELS OF REDOX METABOLISM AND ARTERIAL DYSFUNCTION$221,340
P01 · FY2011 · HL · contact PI
ADMINISTRATION$91,760
P01 · FY2011 · HL · contact PI
Arterial Dysfunction: Basic and Clinical Mechanisms$1,842,936
P01 · FY2010 · HL · contact PI
Endothelial nitric oxide synthase$433,659
R01 · FY2010 · HL · contact PI
REDOX REGULATION OF eNOS SIGNALING PATHWAYS IN VASCULAR ENDOTHELIUM$409,946
P01 · FY2010 · HL · contact PI
ANIMAL MODELS OF REDOX METABOLISM AND ARTERIAL DYSFUNCTION$221,015
P01 · FY2010 · HL · contact PI
ADMINISTRATION$91,754
P01 · FY2010 · HL · contact PI
Arterial Dysfunction: Basic and Clinical Mechanisms$2,103,499
P01 · FY2009 · HL · contact PI
Endothelial nitric oxide synthase$433,659
R01 · FY2009 · HL · contact PI
Protein interactions in cardiovascular signaling$395,903
R01 · FY2009 · GM · contact PI
Protein interactions in cardiovascular signaling$257,773
R01 · FY2009 · GM · contact PI
Insulin and Receptor-Modulated Pathways of eNOS Regulation$154,720
P01 · FY2009 · HL · contact PI
Arterial Dysfunction: Basic and Clinical Mechanisms$2,013,233
P01 · FY2008 · HL · contact PI
Endothelial nitric oxide synthase$433,659
R01 · FY2008 · HL · contact PI
Protein interactions in cardiovascular signaling$395,903
R01 · FY2008 · GM · contact PI
Insulin and Receptor-Modulated Pathways of eNOS Regulation$153,573
P01 · FY2008 · HL · contact PI
Arterial Dysfunction: Basic and Clinical Mechanisms$2,010,068
P01 · FY2007 · HL · contact PI
Endothelial nitric oxide synthase$433,659
R01 · FY2007 · HL · contact PI
Protein interactions in cardiovascular signaling$395,903
R01 · FY2007 · GM · contact PI
Insulin and Receptor-Modulated Pathways of eNOS Regulation$154,136
P01 · FY2007 · HL · contact PI
Arterial Dysfunction: Basic and Clinical Mechanisms$2,075,839
P01 · FY2006 · HL · contact PI
Protein interactions in cardiovascular signaling$407,727
R01 · FY2006 · GM · contact PI
Insulin and Receptor-Modulated Pathways of eNOS Regulation$160,000
P01 · FY2006 · HL · contact PI
Arterial Dysfunction: Basic and Clinical Mechanisms$2,083,243
P01 · FY2005 · HL
Endothelial nitric oxide synthase$432,500
R01 · FY2005 · HL
Protein interactions in cardiovascular signaling$369,816
R01 · FY2005 · GM
Insulin and Receptor-Modulated Pathways of eNOS Regulation$150,000
P01 · FY2005 · HL
Administration$139,600
P01 · FY2005 · HL
Endothelial nitric oxide synthase$432,500
R01 · FY2004 · HL
Protein interactions in cardiovascular signaling$389,250
R01 · FY2004 · GM
Endothelial nitric oxide synthase$432,500
R01 · FY2003 · HL
Protein interactions in cardiovascular signaling$389,250
R01 · FY2003 · GM
CLINICAL SCIENCES$1,595,000
U09 · FY2002 · RG
CLINICAL SCIENCES$934,000
U09 · FY2002 · RG
Endothelial nitric oxide synthase$431,875
R01 · FY2002 · HL
Protein interactions in cardiovascular signaling$408,122
R01 · FY2002 · GM
INTRACELLULAR ASSEMBLY AND TARGETING OF SIGNALING MOLECULES IN HEART FAILURE$214,676
P50 · FY2002 · HL
Endothelial nitric oxide synthase$20,589
R01 · FY2002 · HL
G PROTEIN INTERACTIONS WITH EFFECTORS AND MODULATORS$587,601
R01 · FY2001 · GM
CLINICAL SCIENCES$582,000
U09 · FY2001 · RG
CLINICAL SCIENCES$581,000
U09 · FY2001 · RG
CLINICAL SCIENCES$581,000
U09 · FY2001 · RG
Endothelial nitric oxide synthase$428,438
R01 · FY2001 · HL
CLINICAL SCIENCES$250,000
U09 · FY2001 · RG
INTRACELLULAR ASSEMBLY AND TARGETING OF SIGNALING MOLECULES IN HEART FAILURE$214,676
P50 · FY2001 · HL
G PROTEIN INTERACTIONS WITH EFFECTORS AND MODULATORS$576,329
R01 · FY2000 · GM
CLINICAL SCIENCES$476,000
U09 · FY2000 · RG
ENDOTHELIAL NITRIC OXIDE SYNTHASE$400,729
R01 · FY2000 · HL
INTRACELLULAR ASSEMBLY AND TARGETING OF SIGNALING MOLECULES IN HEART FAILURE$214,676
P50 · FY2000 · HL